AAA
AUTL
Affinity Asset Advisors’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.94M | Hold |
3,045,000
| – | – | 0.95% | 30 |
|
|
2025
Q1 | $4.72M | Sell |
3,045,000
-1,455,000
| -32% | -$2.26M | 0.45% | 37 |
|
|
2024
Q4 | $10.6M | Hold |
4,500,000
| – | – | 1.42% | 23 |
|
|
2024
Q3 | $16.3M | Buy |
4,500,000
+200,000
| +5% | +$726K | 2.23% | 12 |
|
|
2024
Q2 | $15M | Buy |
4,300,000
+925,000
| +27% | +$3.22M | 1.72% | 15 |
|
|
2024
Q1 | $21.5M | Buy |
3,375,000
+1,824,592
| +118% | +$11.6M | 2.67% | 5 |
|
|
2023
Q4 | $9.98M | Sell |
1,550,408
-442,058
| -22% | -$2.85M | 1.82% | 19 |
|
|
2023
Q3 | $4.64M | Buy |
1,992,466
+403,449
| +25% | +$940K | 1.31% | 20 |
|
|
2023
Q2 | $3.78M | Buy |
+1,589,017
| New | +$3.78M | 1.32% | 22 |
|